Regulatory Review Time of Vaccine Approvals in China Between 2005 and 2024
This cross-sectional study examines the regulatory review times for vaccine product applications submitted through China’s National Medical Products Administration over the past 2 decades.
Authors
- Yiming Ding (ORCID: https://orcid.org/0000-0003-0953-3359)
- Reshma Ramachandran (ORCID: https://orcid.org/0000-0003-3845-3606)
- Luwen Shi (ORCID: https://orcid.org/0000-0003-2683-6685)
- Joseph S. Ross (ORCID: https://orcid.org/0000-0002-9218-3320)
- Mengyuan Fu (ORCID: https://orcid.org/0000-0001-9703-8408)
- Xiaodong Guan (ORCID: https://orcid.org/0000-0002-1290-3827)
Institutions
- Peking University (CN)
- Yale University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.18255
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation
- Arnold Ventures
- National Natural Science Foundation of China
- Stavros Niarchos Foundation
- Agency for Healthcare Research and Quality
- National Heart, Lung, and Blood Institute